medigraphic.com

2011, Number 1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2011; 49 (1)

A clinical practice guideline for diagnosis and treatment of chronic obstructive pulmonary disease

Huízar-Hernández V, Rodríguez-Parga D, Sánchez-Mécatl MÁ, Nájera-Cruz MP, Alvarado-Fuentes J, Torres-Arreola LP

Language: Spanish
References: 15
Page: 89-100
PDF size: 111.34 Kb.


ABSTRACT

The World Health Organization (WHO) in 2000 considered that 274 million people died in the world because of chronic obstructive pulmonary disease (COPD). Global mortality by COPD depends on the stage of the disease and 30 to 48 % die during the next four to seven years after the diagnosis. The global burden of disease for the 2020 measurement through the years of potential life lost (YPLL) estimates that COPD is in the 10th place at world-wide level. The great variability in the care of the patients with COPD, as well as the increase in the number of patients with acute exacerbations makes necessary the development of a clinical practice guideline to standardize the treatment and the interventions of rehabilitation, nutrition in the three levels of health care with the objective to improve the quality of care and to promote the efficient use of the resources.


REFERENCES

  1. Halpin D, Miravitlles M. Chronic obstructive pulmonary disease, the disease and its burden to society. Proc Am Thorac Soc 2006;3(7):619-623.

  2. Hill K, Goldstein RS, Guyatt GH, Blouin M, Tan WC, Davis LL, et al. Prevalenced underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ 2010;182(7):673-678. Disponible en http://www.ncbi. nlm.nih.gov/pmc/articles/PMC2855915/pdf/1820673.pdf

  3. Menezes AM, Pérez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005;366(9500):1875-1881.

  4. Cox BD. Blood pressure and respiratory function. En: The health and lifestyle survey. Preliminary report of a nationwide survey of the physical and mental health, attitudes and lifestyle of a random sample of 9003 British adults. London: Health Promotion Research; 1987. p. 17-33.

  5. Solanes I, Pere C. Causas de muerte y predicción de mortalidad en la EPOC. Arch Bronconeumol 2010;46:343-346.

  6. Murray CJ, Lopez AD: The global burden of disease in 1990: final results and their sensitivity to alternative epidemiological perspectives, discount rates, age-weights and disability weights. En: Murray CJ, Lopez AD, editors. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Boston: Harvard School of Public; 1996. p. 247-293.

  7. AGREE Collaborative Group. Guideline development in Europe: an international comparison. Int J Technol Assess Health Care 2000;16(4):1039-1049.

  8. AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREEE project. Qual Saf Health Care 2003;12(1):18-23. Disponible en http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1743672/pdf/v012p00018.pdf

  9. Guía de práctica clínica de diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica. [Monografía en internet]. SEPAR-ALAT; 2007. Disponible en www. separ.es

  10. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. [Monografia en internet]. London: National Clinical Guideline Centre; 2004. Disponible en http://www.nice.org.uk/nicemedia/live/13029/49425/49425.pdf

  11. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-946. Disponible en http://erj.ersjournals.com/content/23/6/932.full.pdf+html

  12. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2006. Oregon,USA: GOLD; 2006.

  13. O´Donnell DE, Aaron S, Bourbeau J, Hernández P, Marciniuk DD, Balter M, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease. Can Resp J 2007;14(Supl B):5B-32B. Disponible en http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806792/pdf/crj14005b.pdf

  14. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, et al. Pulmonary rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007;131(Supl 5):4S-42S.

  15. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J; American Thoracic Society/European Respiratory Society. Statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173(12):1390-1413. Disponible en http://ajrccm.atsjournals.org/cgi/reprint/173/12/1390




2020     |     www.medigraphic.com